DAC-002(Helioson )

N/A

Report date: 2026/05/15 16:30:26

Base Information

Drug NameDAC-002(Helioson )
Drug Alias NameDAC-002DAC002DAC-002(Helioson )DAC002(Helioson )
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody degrader conjugate
Mechanisms of ActionAnti-CD38DNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsLymphocyte differentiation antigen CD38DNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Helioson Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Helioson Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A